According to Citius Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$8.79. a decrease over its 2023 EPS that were of -$8.90.
Year | EPS | Change |
---|---|---|
2024 | -$9.54 | 7.18% |
2023 | -$8.90 | -3.13% |
2022 | -$9.19 | -0% |
2021 | -$9.19 | -48.89% |
2020 | -$17.97 | -41.56% |
2019 | -$30.75 | -34.19% |
2018 | -$46.72 | -38.1% |
2017 | -$75.48 | -17.47% |
2016 | -$91.45 | 67.15% |
2015 | -$54.71 | |
2014 | N/A | -100% |
2013 | -$1.67 | 42.55% |
2012 | -$1.17 | |
2011 | N/A |